Search Results for "Hepatomegaly In Dengue Haemorrhagic Fever"

06:09 EDT 4th July 2015 | BioPortfolio

Matching Channels

Dengue Hemorrhagic Fever

Dengue Virus Vaccines

It is estimated that about 100 million cases of infection by Dengue virus occur each year and that nearly half the world’s population is at risk of Dengue virus infection. At present, no vacci...

Dengue

Q Fever

Fever

Matching News

Making Dengue the Next Vaccine-Preventable Disease

Each year, there are approximately 50 million Dengue infections and an estimated 500,000 individuals are hospitalized with Dengue haemorrhagic fever. There have been attempts to ... The post Making De...

Trial results raise hope for dengue fever vaccine

A tetravalent dengue vaccine has shown efficacy against dengue fever and severe dengue fever and led to fewer hospitalisations in a randomised, blinded, placebo controlled trial.The efficacy trial,......

A very personal perspective on Dengue fever

Leah Katzelnick was all set for a career as an anthropologist until she contracted dengue fever. She was in hospital for a week with severe symptoms. It changed her life. She is now working on a new p...

Dengue fever and chikungunya: identification in travellers

With travel to the tropics more common than ever before, viral infections such as dengue fever and chikungunya should be suspected in travellers who develop a fever and fatigue.

Dengue fever outbreak infects thousands in war-torn Yemen

SANAA, Yemen (AP) — Thousands of people have been diagnosed with dengue fever in southern Yemen, where fighting has raged for months between Shiite rebels and their opponents, international organiz...

Haemorrhagic Fevers Can Be Caused by Body’s Antiviral Interferon Response

Haemorrhagic fevers caused by Lassa, dengue and other viruses affect more than one million people annually and are often fatal, yet scientists have never understood why only some virus-infected people...

Project to fight dengue fever proves a sustainable success

A University of Kansas co-sponsored effort to engage communities to fight the mosquito-borne infectious disease dengue fever in poor Costa Rican villages has proven so effective, residents are continu...

Sumitomo Chemical develops SumiLarv 2 MR to prevent dengue fever

Sumitomo Chemical is pleased to announce that it has developed SumiLarv 2 MR, a novel, long - lasting larvicide formulation that is effective in preventing dengue fever.

Matching PubMed Articles

Trends of fluid requirement in dengue fever and dengue haemorrhagic fever: a single centre experience in Sri Lanka.

Meticulous fluid management is the mainstay of treatment in dengue fever that is currently governed by consensus guidelines rather than by strong research evidence. To examine this issue we audited th...

Dengue fever: Natural management.

Dengue fever is caused by the mosquito-borne dengue virus (DENV) serotypes 1-4, and is the most common arboviral infection of humans in subtropical and tropical regions of the world. Dengue virus infe...

Evaluation of dengue fever reports during an epidemic, Colombia.

OBJECTIVE To assess the validity of dengue fever reports and how they relate to the definition of case and severity. METHODS Diagnostic test assessment was conducted using cross-sectional sampling fro...

Cost-utility analysis of an adjunctive recombinant activated factor VIIa for on-demand treatment of bleeding episodes in dengue haemorrhagic fever.

The present study aimed to assess the cost-utility analysis of using an adjunctive recombinant activated factor VIIa (rFVIIa) in children for controlling life-threatening bleeding in dengue haemorrhag...

Bilateral acute visual loss from Rathke's cleft cyst apoplexy in a patient with dengue fever.

Hemorrhagic complications of optic pathway diseases are extremely rare causes of acute visual loss associated with dengue fever. In this paper we report a patient presenting with dengue fever and bila...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement